KBI Biopharma
We're hiring — explore open roles below and apply in a few clicks.
Location
Headquarters: Durham, North Carolina, United States, North America
Region: North Carolina
Country: US
Continent: North America
About
KBI Biopharma is a global contract development and manufacturing organization (CDMO/CMO) offering end-to-end biologics services, including cell line development, process analytical and formulation development, and clinical to commercial manufacturing. The company provides fully integrated, accelerated drug development and biomanufacturing for pharmaceutical and biotechnology partners worldwide. Its capabilities span both mammalian and microbial modalities with a focus on improving speed to clinic and scale-up for biologics. Headquartered with global locations, KBI Biopharma positions itself as a leading partner in biologics development and manufacturing.
KBI Biopharma is a contract development and manufacturing organization (CDMO) providing end-to-end biologics services for pharmaceutical and biotechnology companies. The firm offers cell line development, process analytical and formulation development, and clinical to commercial manufacturing for mammalian and microbial programs. It operates as a subsidiary of JSR Life Sciences.
KBI Biopharma, Inc.
1996
for_profit
active
Industries
Primary Industry: Business Services
Categories
Funding & Financials
series_unknown
9600000
50m-100m
private
Investors
Leadership
Sigma Mostafa — Chief Scientific Officer
Jesse Kingg — VP Manufacturing & Site Head Commercial Mfg. Facility
Abhinav Shukla — Sr. Vice President, Process Development and Manufacturing
Niket Bubna — Associate Director
Marykay Marchigiani — Chief Financial Officer
Doris Michor — Chief Operating Officer
Technology Stack
Products
Cell Line Development: Services for developing mammalian and microbial cell lines to support biopharmaceutical production and cGMP manufacturing.
Process Development: Development of scalable and reproducible processes for mammalian and microbial biologics production from early-stage to cGMP manufacturing.
Analytical Development and Characterization: Comprehensive analytical testing, biophysical characterization, mass spectrometry, and modeling to support biologics development and manufacturing.
Formulation Development: Development of optimized formulations for biologics using data-driven approaches to enhance stability and delivery.
Clinical Manufacturing: cGMP manufacturing of biologics for clinical trials, including mammalian and microbial expression systems with release and stability testing.
Commercial Manufacturing: cGMP manufacturing of biologics for commercial supply, including mammalian and microbial production with release and stability testing.
Funding rounds
LATE_VC · 99870000 · (2025-10-01T00:00:00)
EARLY_VC · 9600000 · (2009-09-01T00:00:00)